)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Samsung Biologics
Samsung Biologics (207940) investor relations material
Samsung Biologics Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary23 Jul, 2026
Executive summary
Achieved 30% year-over-year revenue growth in Q2 2026, driven by full utilization of Plants 1-4 and favorable FX rates.
Operating profit rose 23% year-over-year, maintaining a robust mid-40% margin despite pre-revenue costs from Plant 5 and the US facility.
Completed a spin-off in November 2025, separating the biopharma development and commercialization business into Samsung Epice Holdings.
Expanded global production capacity to 845,000 liters after acquiring Human Genome Sciences, Inc. in the US.
Announced acquisition of Swiss-based PolyPeptide Group AG to expand peptide CDMO capabilities.
Financial highlights
Q2 2026 revenue: KRW 1,321B (+30% YoY); operating profit: KRW 586B (+23% YoY); net profit: KRW 431B.
H1 2026 revenue: KRW 2,578B (+28% YoY); operating profit: KRW 1,167B (+29% YoY); net profit: KRW 900B.
EBITDA margin improved to 52.9% in Q2 2026.
Gross margin: 53.5% for H1 2026.
Cash and cash equivalents increased to KRW 2,189B as of Q2 2026.
Outlook and guidance
FY26 revenue growth guidance maintained at +15-20% YoY, targeting the upper end.
Biopharma CDMO market expected to grow at 15.4% CAGR through 2029.
Plant 5 and US facility expected to be key growth drivers; revenue recognition from US facility to begin in Q3.
Company expanding into mRNA, ADC, and cell/gene therapy CDMO services.
Production disruptions in Q2 mitigated by rescheduling and favorable FX.
Mitigation of Q2 batch production disruptions
Strategic rationale for PolyPeptide acquisition
Growth strategy for new platform licensing-out
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Samsung Biologics
- Q1 2026 delivered record revenue and profit, with expanded U.S. capacity and strong CDMO growth.207940
Q1 2026 - 30% revenue growth in 2025, major contracts, and global expansion drive strong outlook.207940Q4 2025
- Q3 2025 revenue up 40% YoY, operating profit up 115%, with robust growth and margin expansion.207940Q3 2025
- Q2 revenue up 11% YoY, H1 net income KRW 699.9B, guidance raised, spin-off underway.207940Q2 2025
- Revenue for the first nine months of 2024 was ₩3.29T, with raised growth guidance and major deals.207940Q3 2024
- Q2 revenue up 34% YoY, H1 revenue KRW 2.10T, strong CDMO and biosimilar growth.207940Q2 2024
- Spin-off creates SEH to manage investments, enabling SBL and SBE to pursue focused growth.207940Investor Presentation
- Q1 2025 saw record revenue, robust CDMO margins, and major global expansion initiatives.207940Q1 2025
- Record revenue growth and major contract wins set stage for continued expansion in 2025.207940Q4 2024
Next Samsung Biologics earnings date
Q3 202613 Nov, 2026
Samsung Biologics
Next Samsung Biologics earnings date
Q3 202613 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage